Brief: DSM-Firmenich Q1 Adj. EBITDA Margin Up At 19.9%
April 30 (Reuters) - DSM-Firmenich AG DSFIR.AS: Q1 2025 TRADING UPDATE OUTLOOK FY ADJUSTED EBITDA EUR 2,400 MILLION Q1 2025 ADJUSTED EBITDA MARGIN IMPROVES TO 19.9% 8% ORGANIC SALES GROWTH IN Q1 Source text: ID:nGNE2hX5ls Further company coverage: DSFIR.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on DSM-Firmenich AG
See all newsAnalysis: Brazil's corn ethanol boom accelerating growth of feedlot beef
Top of the Street: Hensoldt, Unilever, Evonik, dsm-firmenich, IMCD, AAK
Weak US sentiment hurts dietary supplement sales, offsetting broader growth, Novonesis CEO says
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Dsm-firmenich raises growth outlook in line with expectations (updated)